When using both peptides, athletes often report quicker recovery times
Shim, S
This personalized, accessible approach allows hypothyroid patients to find their optimal weight loss medication strategy with physician guidance and genetic precision
Were here to support you on your journey to better health
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)
Yurci A, Kalkan AO, Ozbakir O, Karaman A, Torun E, Kula M,